Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
Cronos Group Inc is a drug manufacturers—specialty & generic business based in the US. Cronos Group shares (CRON) are listed on the NASDAQ and all prices are listed in US Dollars. Cronos Group employs 631 staff and has a trailing 12-month revenue of around USD$31.4 million.
Since the stock market crash in March caused by coronavirus, Cronos Group's share price has had significant negative movement.
Its last market close was USD$6.07, which is 15.10% down on its pre-crash value of USD$7.15 and 51.75% up on the lowest point reached during the March crash when the shares fell as low as USD$4.
If you had bought USD$1,000 worth of Cronos Group shares at the start of February 2020, those shares would have been worth USD$718.08 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$851.32.
|Latest market close||USD$6.07|
|52-week range||USD$4.43 - USD$9.19|
|50-day moving average||USD$5.3386|
|200-day moving average||USD$5.9419|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.952|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-10-22)||6.07|
|1 month (2020-09-29)||20.20%|
|3 months (2020-07-29)||-10.07%|
|6 months (2020-04-29)||-2.57%|
|1 year (2019-10-29)||-27.48%|
|2 years (2018-10-29)||-10.74%|
|3 years (2017-10-27)||147.73%|
|5 years (2015-10-25)||N/A|
Valuing Cronos Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cronos Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cronos Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Cronos Group shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||USD$31.4 million|
|Gross profit TTM||USD$-15,964,000|
|Return on assets TTM||-5.46%|
|Return on equity TTM||48.76%|
|Market capitalisation||USD$2 billion|
TTM: trailing 12 months
There are currently 48.9 million Cronos Group shares held short by investors – that's known as Cronos Group's "short interest". This figure is 1.2% down from 49.5 million last month.
There are a few different ways that this level of interest in shorting Cronos Group shares can be evaluated.
Cronos Group's "short interest ratio" (SIR) is the quantity of Cronos Group shares currently shorted divided by the average quantity of Cronos Group shares traded daily (recently around 2.6 million). Cronos Group's SIR currently stands at 19.17. In other words for every 100,000 Cronos Group shares traded daily on the market, roughly 19170 shares are currently held short.
However Cronos Group's short interest can also be evaluated against the total number of Cronos Group shares, or, against the total number of tradable Cronos Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cronos Group's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 Cronos Group shares in existence, roughly 140 shares are currently held short) or 0.2707% of the tradable shares (for every 100,000 tradable Cronos Group shares, roughly 271 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Cronos Group.
Find out more about how you can short Cronos Group stock.
We're not expecting Cronos Group to pay a dividend over the next 12 months.
Over the last 12 months, Cronos Group's shares have ranged in value from as little as $4.43 up to $9.19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cronos Group's is 1.7539. This would suggest that Cronos Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.
Steps to owning and managing WK, with 24-hour and historical pricing before you buy.
Steps to owning and managing HCN, with 24-hour and historical pricing before you buy.
Steps to owning and managing VEL, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEA, with 24-hour and historical pricing before you buy.
Steps to owning and managing LUB, with 24-hour and historical pricing before you buy.
Steps to owning and managing HCSG, with 24-hour and historical pricing before you buy.
Steps to owning and managing LAWS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SWIR, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing CSIQ, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.